A sailor’s experiment
In 1747, Scottish naval surgeon James Lind performed what’s now thought of the world’s first managed clinical trial aboard HMS Salisbury. Scurvy, a virulent disease inflicting bleeding gums and fatigue, was devastating for sailors. Unaware of nutritional vitamins, at that stage, Lind divided 12 affected sailors into six pairs, every receiving a unique remedy. Only these given oranges and lemons recovered. Though vitamin C wouldn’t be recognized for one more century, Lind’s use of comparability and statement led to a medical breakthrough. His experiment laid the muse for contemporary clinical trials—structured research on people to assess the security and effectiveness of therapies, vaccines, or preventive interventions.
What is a trial?
A clinical trial begins with a query and ends with a verdict— the end result is effectiveness or failure. A clinical trial is an organised technique of figuring out whether or not one strategy to remedy is best than one other. These trials developed enormously in the course of the twentieth century. In 1948, British epidemiologist Sir Austin Bradford Hill launched the randomised managed trial, testing the efficacy of streptomycin in pulmonary tuberculosis. Randomising contributors to totally different teams—one receiving the experimental drug and one other a placebo—diminished bias and improved inference high quality. Randomisation, blinding, and managed comparisons grew to become the cornerstones of recent clinical analysis.
Also Read: ICMR indicators MoAs to advance first-in-human clinical trials for 4 promising molecules
Types and phases of clinical trials
Clinical trials fluctuate in design based mostly on the analysis query. In a parallel trial, totally different teams obtain totally different therapies all through. In a crossover trial, every participant receives each therapies in sequence. Other designs embody factorial trials, testing a number of interventions concurrently, and cluster trials, randomising teams moderately than people. Blinding and placebos assist scale back bias and isolate true remedy results. Before human testing, new medication bear preclinical research in labs and animals. Phase 1 assesses security in wholesome volunteers by way of microdosing. Phase 2 evaluates early effectiveness in sufferers. Phase 3 compares with customary care in giant, multi-centre trials. Phase 4, after approval, displays long-term security in real-world settings. These phases guarantee scientific rigour and public security at each step.
Yet, for all of the rigour in conducting these research, an issue persevered: selective reporting. Often, solely beneficial outcomes discovered their method into journals, whereas unfavourable or inconclusive trials had been quietly buried. This distorted the proof panorama, misled clinicians, and led to wastage of sources due to the repetition of unsuccessful and unpublished trials.
To enhance, the idea of clinical trial, registries was born. These registries act as public ledgers, documenting the intention to conduct a trial and the protocol, strategies, and outcomes no matter whether or not the examine sees the sunshine of publication.
Inside a registry
A clinical trial registry consists of a variety of knowledge: the trial title, sponsor and funding particulars, scientific rationale, moral approvals, inclusion and exclusion standards, intervention and comparator arms, main and secondary outcomes, recruitment standing, anticipated begin and finish dates, and updates on outcomes or termination. The most well-known international registry, ClinicalTrials.gov, was launched in 2000 by the U.S. National Library of Medicine. The broader motion for worldwide harmonisation started with the World Health Organization’s International Clinical Trials Registry Platform (ICTRP), established in 2006, which linked a number of nationwide registries throughout the globe. The WHO’s International Clinical Trials Registry Platform just isn’t for direct registration; researchers should register by way of one among 17 recognised main registries globally. The aim was easy: wherever on the planet, any human clinical trial ought to be prospectively registered in a public database accessible to all for data sharing and participation in trials.
Rise of regulation
Over the years, clinical trial registration grew to become greater than a finest apply—it grew to become necessary. The International Committee of Medical Journal Editors (ICMJE) introduced that no member journal would publish outcomes of trials that weren’t registered earlier than affected person enrolment. WHO formulated minimal dataset necessities for trial registries and known as upon governments and establishments to make trial registration a authorized obligation. Countries reminiscent of India responded swiftly. The Clinical Trials Registry – India (CTRI) was launched in July 2007 by the National Institute of Medical Statistics beneath the Indian Council of Medical Research. By 2009, it grew to become necessary to register all interventional trials performed in India prospectively. Registering a trial in CTRI requires the investigator to create an account, fill out the structured trial registration information set on-line, connect related ethics committee approvals, and submit for verification. CTRI directors evaluate data, and a novel registration quantity is issued as soon as it’s accepted.
WHO’s 2025 replace
Despite these strides, gaps remained. A major variety of trials, even after registration, failed to report their outcomes publicly. In April 2025, WHO launched a long-awaited steerage doc to plug this hole. The new guideline mandates that inside 12 months of trial completion, abstract outcomes have to be made obtainable within the registry. The steerage identifies eight minimal parts to be reported: the ultimate trial protocol and statistical evaluation plan (together with amendments), the completion standing and whether or not the trial ended early, dates of reporting each within the registry and journals, participant stream throughout arms, baseline participant traits, detailed end result outcomes (together with subgroup analyses and comparisons), harms or adversarial occasions, and declarations of battle of curiosity by the investigators.
This new technical advisory attracts inspiration from the CONSORT 2025 reporting requirements utilized in educational publishing, bringing consistency between what’s printed in journals and what’s recorded in registries. It additionally encourages utilizing structured fields for reporting, which improves searchability, aggregation, and monitoring of world well being analysis. WHO’s platform is now working in the direction of integrating these updates right into a mixed ‘Registration and Results Data Set.’
This change displays a profound moral precept: each trial should contribute to scientific data, even when the result’s inconclusive, unfavourable, or deserted halfway. Trials are now not seen as closed educational workouts however as public items. A failed trial, transparently reported, is as useful as a profitable one—it prevents duplication, protects sufferers, and refines analysis. Like silent archivists, registries guarantee each information level finds a spot in historical past and that each participant’s contribution is totally acknowledged. The registry is a quiet custodian of reality in a world grappling with medical misinformation and hurried improvements.
(Dr. C. Aravinda is an instructional and public well being doctor. The views expressed are private. aravindaaiimsjr10@hotmail.com)
Published – June 17, 2025 03:57 pm IST
